Relugolix

CHEBI:CHEBI_749854

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2472789
generic_name
Relugolix (Form-I)
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20241231
route
ORAL
dosage_form
POWDER
pharm_class_moa
Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
pharm_class
Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
nui
N0000187064
marketing_start_date
20240802
package_marketing_start_date
18-DEC-20
active_ingredient_name
RELUGOLIX
unii
P76B05O5V6
pharm_class_epc
Gonadotropin Releasing Hormone Receptor Antagonist [EPC]
pharm_class_pe
Decreased GnRH Secretion [PE]
labeler_name
Hetero Labs Limited
manufacturer_name
Sumitomo Pharma America, Inc.
active_ingredient_strength
75 kg/75kg
product_ndc
51148-013
spl_id
eeb6a79c-f12f-30ce-e053-2995a90a818d
package_ndc
51148-013-01
package_description
1 BAG in 1 DRUM (51148-013-01) / 134000 TABLET, FILM COATED in 1 BAG
brand_name
Orgovyx
brand_name_base
Orgovyx
application_number
NDA214621
spl_set_id
077a92f6-9f1b-479a-87c7-c92b5db6aa9c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class